Research Progress on the Animal Models of Drug-Induced Liver Injury: Current Status and Further Perspectives
Overview
Biotechnology
General Medicine
Affiliations
Drug-induced liver injury (DILI) is a major concern in clinical studies as well as in postmarketing surveillance. It is necessary to establish an animal model of DILI for thorough investigation of mechanisms of DILI and searching for protective medications. This article reviews the current status and future perspective on establishment of DILI models based on different hepatotoxic drugs, as well as the underlying mechanisms of liver function damage induced by specific medicine. Therefore, information from this article can help researchers make a suitable selection of animal models for further study.
In Vitro Hepatotoxicity of Routinely Used Opioids and Sedative Drugs.
Haller K, Doss S, Sauer M Curr Issues Mol Biol. 2024; 46(4):3022-3038.
PMID: 38666919 PMC: 11049542. DOI: 10.3390/cimb46040189.
Zhao S, Feng Y, Zhang J, Zhang Q, Wang J, Cui S BMC Med Genomics. 2024; 17(1):80.
PMID: 38549107 PMC: 10976682. DOI: 10.1186/s12920-024-01848-0.
Zheng X, Wu X, Wen Q, Tang H, Zhao L, Shi F Nutrients. 2023; 15(20).
PMID: 37892424 PMC: 10609606. DOI: 10.3390/nu15204349.
Baek E, Lee J, Hwang J, Park H, Lee B, Kim Y Sci Rep. 2023; 13(1):17555.
PMID: 37845356 PMC: 10579263. DOI: 10.1038/s41598-023-44897-8.
Moein M, Heinonen M, Mesens N, Chamanza R, Amuzie C, Will Y Chem Res Toxicol. 2023; 36(8):1238-1247.
PMID: 37556769 PMC: 10445287. DOI: 10.1021/acs.chemrestox.2c00378.